Competitive intelligence
Side-by-side comparison
Up to six companies on the same rows. Empty cells say what is missing rather than hiding it.
4 of 6 columns
Comparison
| Attribute | MBQ PHARMA INC.6.6remove | Sentonix, Inc.6.7remove | Ratio Therapeutics, Inc.5.8remove | LifeCyte Innovations, Inc.5.8remove |
|---|---|---|---|---|
| Signal scores | ||||
| Radar composite | 6.6 | 6.7 | 5.8 | 5.8 |
| IPO signal score | 13.2 | 13.4 | 11.6 | 11.6 |
| Tokenization signal score | 0.0 | 0.0 | 0.0 | 0.0 |
| On-chain readiness | 0.0 | 0.0 | 0.0 | 0.0 |
| Momentum | STABLE+4.6 | STABLE+3.5 | STABLE0.0 | STABLE+3.0 |
| Company | ||||
| Stage | private | private | private | private |
| Sector | Health Care | Health Care | Health Care | Health Care |
| Headquarters | SAN JUAN, United States | ARLINGTON, United States | BOSTON, United States | GREENSBORO, United States |
| Founded | not on record | 2023 | not on record | 2024 |
| Employees | not on record | not on record | not on record | not on record |
| Capital | ||||
| Latest valuation | not on record | not on record | not on record | not on record |
| Total funding | $4M | $13M | $70M | $1M |
| Latest round | Private Placement $2M | Private Placement $13M | Private Placement $70M | Private Placement $1M |
| Investors on record | 0 | 0 | 0 | 0 |
| Evidence | ||||
| Institutional relationships | 0 | 0 | 0 | 0 |
| Active signals | 5 | 1 | 1 | 1 |
| Confidence | 67% | 53% | 53% | 53% |
IPO Radar is a research and intelligence tool. Scores are signal scores derived from public evidence — they are not calibrated probabilities and not investment advice. FACT, INFERENCE and PREDICTION are kept separate, and every event links to its source.